Literature DB >> 28748725

Recent Trends in the Prescribing of ADHD Medications in Canadian Primary Care.

Rachael Morkem1, Scott Patten2, John Queenan1, David Barber1.   

Abstract

Objective: The aim of this study was to describe the prevalence and incidence of ADHD medication prescribing, by age and gender, from 2005 to 2015 in Canadian primary care. Method: A population-based retrospective cohort study was conducted to evaluate the prescribing of ADHD medications between 2005 and 2015 using electronic medical record data. Yearly prevalence and incidence of ADHD medication prescribing were calculated for preschoolers (up to 5 years old), school-aged children (6-17 years old), and adults (18-65 years old) along with a description of the types of ADHD medications prescribed between 2005 and 2015.
Results: Between 2005 and 2015, there was a 2.6-fold increase in the prevalence of ADHD medication prescribing to preschoolers, a 2.5-fold increase in school-aged children, and a fourfold increase in adults. There was a corresponding rise in incidence of prescribing although this rise was moderate and estimates were much lower compared with prevalence. The most commonly prescribed medication was Methylphenidate (65.0% of all ADHD medications prescribed).
Conclusion: Although the prevalence of ADHD has remained stable over time, this study found an increase in the prescribing of ADHD medications in all age groups between 2005 and 2015. Incidence of new prescriptions was small relative to prevalence, suggesting that longer term treatments are being adopted.

Entities:  

Keywords:  pharmacological treatment; population-based study; prescription prevalence; psychostimulant

Mesh:

Substances:

Year:  2017        PMID: 28748725     DOI: 10.1177/1087054717720719

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  4 in total

1.  Changes in Provider Type and Prescription Refills Among Privately Insured Children and Youth With ADHD.

Authors:  Laura C Hart; Scott D Grosse; Melissa L Danielson; Rebecca A Baum; Alex R Kemper
Journal:  J Atten Disord       Date:  2020-09-18       Impact factor: 3.256

2.  Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.

Authors:  Maxim Lemelin; Takoua Boukhris; Jin-Ping Zhao; Odile Sheehy; Anick Bérard
Journal:  Pharmacol Res Perspect       Date:  2021-05

3.  Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15-44 Years - United States, 2003-2015.

Authors:  Kayla N Anderson; Elizabeth C Ailes; Melissa Danielson; Jennifer N Lind; Sherry L Farr; Cheryl S Broussard; Sarah C Tinker
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-19       Impact factor: 17.586

4.  Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.

Authors:  Jesse Elliott; Amy Johnston; Don Husereau; Shannon E Kelly; Caroline Eagles; Alice Charach; Shu-Ching Hsieh; Zemin Bai; Alomgir Hossain; Becky Skidmore; Eva Tsakonas; Dagmara Chojecki; Muhammad Mamdani; George A Wells
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.